Navigation Links
ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research

SAN DIEGO--(BUSINESS WIRE)--Mar 29, 2007 - ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the company will present at the 2007 International Congress on Schizophrenia Research, held from March 28 through April 1, 2007, in Colorado Springs, Colorado. Presentations will cover ACADIA's two schizophrenia programs and will include previously announced top-line clinical data from the recently completed ACP-103 Phase II schizophrenia co-therapy trial, as well as preclinical and top-line clinical data on ACP-104 for the treatment of schizophrenia.

ACP-103: Top-Line Data from Phase II Schizophrenia Co-Therapy Trial

Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA, will make an oral presentation on April 1 titled "ACP-103, a 5-HT2A Inverse Agonist in Schizophrenia and Parkinson's Disease Psychosis." This presentation will include previously announced top-line results from the recently completed ACP-103 Phase II schizophrenia co-therapy trial, which highlighted several advantages of co-therapy with ACP-103, including enhanced efficacy, a faster onset of antipsychotic action, and an improved side effect profile. Dr. Hacksell also will present new data from this study showing that patients in the co-therapy arm combining ACP-103 with risperidone (2 mg) had significantly lower prolactin levels after 42 days of treatment compared to patients in the risperidone (6 mg) plus placebo arm (p=0.0001). The condition of elevated prolactin is a commonly observed side effect of antipsychotic therapy and may adversely affect menstrual and sexual function as well as bone formation.

ACP-104: Top-Line Data From Single Ascending-Dose and Multiple Ascending-Dose Studies

Professor Carol Tamminga, M.D., from the University of Texas Sout
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Faust Pharmaceuticals Phase IIa Results for Parkinsons Disease Presented at International Congress of Parkinsons Disease and Movement Disorders
2. Data from Rexahn Pharmaceuticals Phase I Trial of RX-0201 (Archexin) to Be Presented at the 43rd American Society of Clinical Oncology Annual Meeting in Chicago
3. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
4. Aeolus Pharmaceuticals AEOL 10113 May Play an Important Role Regulating the Oxidative Damage Induced by Ionizing Radiation
5. Aeolus Pharmaceuticals AEOL 10113 Demonstrates Potential as a Protector of Healthy Normal Cells from Cancer Radiation Therapy
6. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
7. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
8. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
9. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
10. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
11. New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia
Post Your Comments:
(Date:7/24/2014)... WASHINGTON , July 24, 2014  The ... Brightree is supporting its mission to help address ... new and exclusive agreement to be the information ... service. As the leading provider of billing and ... brings unmatched HME industry expertise to support this ...
(Date:7/24/2014)... , July 24, 2014 Consolidated Net ... Business Highlights   , India Business grew ... by 9.33% to Rs. 4,886.70 Mn Rest of World ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... , Glenmark Pharmaceuticals Limited, the research-led global ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- "North America Orthopedic Braces ... data on the North America Orthopedic Braces and Supports ... dollars, and volume (in units) and average price data ... Knee Braces and Supports , Ankle Braces and ... Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... 8, 2011 The U.S. Food and Drug Administration today launched ... the safe disposal of needles and other so-called "sharps" that ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The website will ... disposing of used sharps and how users should safely dispose ...
... Nov. 8, 2011 Dengue v2V, a group of international ... in Puerto Rico on 5–6 November 2011 to continue to ... licensed. Dengue is a threat to almost half of the ... and Asia where epidemics are common.(1) "Puerto ...
Cached Medicine Technology:FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 2FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 3FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 4International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever 2International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever 3
(Date:7/24/2014)... may have found a way to delay or even ... neurons with the anti-aging protein Klotho can prevent neuron ... and glutamate. These findings currently appear in the ... is the most frequent age-related dementia affecting 5.4 million ... older and more than 40 percent of people over ...
(Date:7/24/2014)... 24, 2014 This year the Walk ... Electric and Jackson National Life, will be held on Saturday, ... am, the Kids Fun Run at 7:50 am, the untimed ... 9 a.m. , “The Walk to End Alzheimer’s unites the ... in the fight against this devastating disease, “stated Linda Mitchell, ...
(Date:7/24/2014)... 24, 2014 (HealthDay News) -- Drinking caffeine may worsen ... two-thirds of women as they go through menopause, new ... our study suggests that limiting caffeine intake may be ... flashes and night sweats," said researcher Dr. Stephanie Faubion, ... Clinic in Rochester, Minn. But caffeine -- a ...
(Date:7/24/2014)... or more equally positive outcomes experience paradoxical feelings ... in different regions of the brain, according to ... scholar at the Princeton Neuroscience Institute at Princeton ... rated the desirability of more than 300 products ... images of paired products with different or similar ...
(Date:7/24/2014)... Le Bonheur Children,s Hospital and the University of Tennessee ... of a new drug shown to safely reduce the ... intranasally infected with respiratory syncytial virus (RSV). RSV is ... in young children in the United States and worldwide. ... Infectious Disease Specialist John DeVincenzo, MD. DeVincenzo,s Le Bonheur ...
Breaking Medicine News(10 mins):Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:Brain's dynamic duel underlies win-win choices 2Health News:Brain's dynamic duel underlies win-win choices 3Health News:RSV research breakthrough to help infected children 2
... with lung cancer remains to be established, a new ... Journal of Thoracic Oncology provides compelling evidence of ... Researchers at China Medical University and Hospital in Taiwan ... National Health Insurance (NHI) program. All patients aged 20 ...
... PROVIDENCE, R.I. [Brown University] A new study of ... seeking a hospice benefit and using it longer. The ... residents die with some degree of dementia. Researchers hope ... benefit even as they seek to control Medicare costs. ...
... By Dennis Thompson HealthDay Reporter , THURSDAY, ... played a big role in averting a major health crisis. ... pitch last winter, with public health officials fearing a widespread ... an epidemic was averted, and some health experts believe that,s ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- A treatment ... of patients suffering from multiple chronic illnesses such as ... in the Dec. 30 issue of the New ... four areas of blood sugar, blood pressure, cholesterol control ...
... Reporter , WEDNESDAY, Dec. 29 (HealthDay News) -- Consider this: ... cancer in the United States, killing about 157,300 people every ... according to the U.S. National Institutes of Health. , It ... only to heart disease. And yet lung cancer ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- People generally ... those of others, according to a new study. ... to 11 people. Each person talked with every other ... rated the other person,s physical attractiveness and five major ...
Cached Medicine News:Health News:Study finds evidence of increased lung cancer risk among tuberculosis patients 2Health News:Hospice care increasing for nursing home patients with dementia 2Health News:Hospice care increasing for nursing home patients with dementia 3Health News:Hand-Washing May Have Kept Flu at Bay 2Health News:Hand-Washing May Have Kept Flu at Bay 3Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 2Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 3Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 2Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 3Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 4
... this technique is acquired tricuspid insufficiency, ... tricuspid repair are based on the ... by angiography and dye dilution curves ... with an irreversible tricuspid insufficiency, the ...
PremierEdge™ Stab Knives - 45°....
PremierEdge™ Stab Knives - 22.5°....
DCR Set, Straight....
Medicine Products: